516 related articles for article (PubMed ID: 21901281)
1. Nicotinamide mononucleotide protects against pro-inflammatory cytokine-mediated impairment of mouse islet function.
Caton PW; Kieswich J; Yaqoob MM; Holness MJ; Sugden MC
Diabetologia; 2011 Dec; 54(12):3083-92. PubMed ID: 21901281
[TBL] [Abstract][Full Text] [Related]
2. Structure-functional changes in eNAMPT at high concentrations mediate mouse and human beta cell dysfunction in type 2 diabetes.
Sayers SR; Beavil RL; Fine NHF; Huang GC; Choudhary P; Pacholarz KJ; Barran PE; Butterworth S; Mills CE; Cruickshank JK; Silvestre MP; Poppitt SD; McGill AT; Lavery GG; Hodson DJ; Caton PW
Diabetologia; 2020 Feb; 63(2):313-323. PubMed ID: 31732790
[TBL] [Abstract][Full Text] [Related]
3. Nampt/PBEF/Visfatin regulates insulin secretion in beta cells as a systemic NAD biosynthetic enzyme.
Revollo JR; Körner A; Mills KF; Satoh A; Wang T; Garten A; Dasgupta B; Sasaki Y; Wolberger C; Townsend RR; Milbrandt J; Kiess W; Imai S
Cell Metab; 2007 Nov; 6(5):363-75. PubMed ID: 17983582
[TBL] [Abstract][Full Text] [Related]
4. Expression and regulation of nampt in human islets.
Kover K; Tong PY; Watkins D; Clements M; Stehno-Bittel L; Novikova L; Bittel D; Kibiryeva N; Stuhlsatz J; Yan Y; Ye SQ; Moore WV
PLoS One; 2013; 8(3):e58767. PubMed ID: 23536823
[TBL] [Abstract][Full Text] [Related]
5. Monocyte-derived extracellular Nampt-dependent biosynthesis of NAD(+) protects the heart against pressure overload.
Yano M; Akazawa H; Oka T; Yabumoto C; Kudo-Sakamoto Y; Kamo T; Shimizu Y; Yagi H; Naito AT; Lee JK; Suzuki J; Sakata Y; Komuro I
Sci Rep; 2015 Nov; 5():15857. PubMed ID: 26522369
[TBL] [Abstract][Full Text] [Related]
6. Monomeric eNAMPT in the development of experimental diabetes in mice: a potential target for type 2 diabetes treatment.
Kieswich J; Sayers SR; Silvestre MF; Harwood SM; Yaqoob MM; Caton PW
Diabetologia; 2016 Nov; 59(11):2477-2486. PubMed ID: 27541013
[TBL] [Abstract][Full Text] [Related]
7. SIRT1-Mediated eNAMPT Secretion from Adipose Tissue Regulates Hypothalamic NAD+ and Function in Mice.
Yoon MJ; Yoshida M; Johnson S; Takikawa A; Usui I; Tobe K; Nakagawa T; Yoshino J; Imai S
Cell Metab; 2015 May; 21(5):706-17. PubMed ID: 25921090
[TBL] [Abstract][Full Text] [Related]
8. Nicotinamide mononucleotide, an intermediate of NAD+ synthesis, protects the heart from ischemia and reperfusion.
Yamamoto T; Byun J; Zhai P; Ikeda Y; Oka S; Sadoshima J
PLoS One; 2014; 9(6):e98972. PubMed ID: 24905194
[TBL] [Abstract][Full Text] [Related]
9. Nicotinamide mononucleotide promotes pancreatic islet function through the SIRT1 pathway in mice after severe burns.
Liu X; Li D; Liu Z; Song Y; Zhang B; Zang Y; Zhang W; Niu Y; Shen C
Burns; 2022 Dec; 48(8):1922-1932. PubMed ID: 35123833
[TBL] [Abstract][Full Text] [Related]
10. Extracellular Nampt promotes macrophage survival via a nonenzymatic interleukin-6/STAT3 signaling mechanism.
Li Y; Zhang Y; Dorweiler B; Cui D; Wang T; Woo CW; Brunkan CS; Wolberger C; Imai S; Tabas I
J Biol Chem; 2008 Dec; 283(50):34833-43. PubMed ID: 18945671
[TBL] [Abstract][Full Text] [Related]
11. Reversal of endothelial dysfunction by nicotinamide mononucleotide via extracellular conversion to nicotinamide riboside.
Mateuszuk Ł; Campagna R; Kutryb-Zając B; Kuś K; Słominska EM; Smolenski RT; Chlopicki S
Biochem Pharmacol; 2020 Aug; 178():114019. PubMed ID: 32389638
[TBL] [Abstract][Full Text] [Related]
12. Nicotinamide mononucleotide-elicited NAMPT signaling activation aggravated adjuvant-induced arthritis in rats by affecting peripheral immune cells differentiation.
Wang QH; Li Y; Dou DY; Wang R; Jiang TT; Wang L; Li MQ; Joshua Olatunji O; Zuo J
Int Immunopharmacol; 2021 Sep; 98():107856. PubMed ID: 34130151
[TBL] [Abstract][Full Text] [Related]
13. Leukocyte Overexpression of Intracellular NAMPT Attenuates Atherosclerosis by Regulating PPARγ-Dependent Monocyte Differentiation and Function.
Bermudez B; Dahl TB; Medina I; Groeneweg M; Holm S; Montserrat-de la Paz S; Rousch M; Otten J; Herias V; Varela LM; Ranheim T; Yndestad A; Ortega-Gomez A; Abia R; Nagy L; Aukrust P; Muriana FJG; Halvorsen B; Biessen EAL
Arterioscler Thromb Vasc Biol; 2017 Jun; 37(6):1157-1167. PubMed ID: 28408371
[TBL] [Abstract][Full Text] [Related]
14. Nicotinamide phosphoribosyltransferase/visfatin does not catalyze nicotinamide mononucleotide formation in blood plasma.
Hara N; Yamada K; Shibata T; Osago H; Tsuchiya M
PLoS One; 2011; 6(8):e22781. PubMed ID: 21826208
[TBL] [Abstract][Full Text] [Related]
15. The adipocytokine Nampt and its product NMN have no effect on beta-cell survival but potentiate glucose stimulated insulin secretion.
Spinnler R; Gorski T; Stolz K; Schuster S; Garten A; Beck-Sickinger AG; Engelse MA; de Koning EJ; Körner A; Kiess W; Maedler K
PLoS One; 2013; 8(1):e54106. PubMed ID: 23342086
[TBL] [Abstract][Full Text] [Related]
16. Nicotinamide Phosphate Transferase (NAMPT) Increases in Plasma in Patients with Acute Coronary Syndromes, and Promotes Macrophages to M2 Polarization.
Zhang C; Zhu R; Wang H; Tao Q; Lin X; Ge S; Zhai Z
Int Heart J; 2018 Sep; 59(5):1116-1122. PubMed ID: 30158377
[TBL] [Abstract][Full Text] [Related]
17. Nicotinamide mononucleotide, a key NAD(+) intermediate, treats the pathophysiology of diet- and age-induced diabetes in mice.
Yoshino J; Mills KF; Yoon MJ; Imai S
Cell Metab; 2011 Oct; 14(4):528-36. PubMed ID: 21982712
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of nicotinamide phosphoribosyltransferase protects against acute pancreatitis via modulating macrophage polarization and its related metabolites.
He Y; Dai J; Niu M; Li B; Chen C; Jiang M; Wu Z; Bao J; Zhang X; Li L; Husain SZ; Hu G; Wen L
Pancreatology; 2021 Aug; 21(5):870-883. PubMed ID: 33810973
[TBL] [Abstract][Full Text] [Related]
19. Novel Mechanism for Nicotinamide Phosphoribosyltransferase Inhibition of TNF-α-mediated Apoptosis in Human Lung Endothelial Cells.
Oita RC; Camp SM; Ma W; Ceco E; Harbeck M; Singleton P; Messana J; Sun X; Wang T; Garcia JGN
Am J Respir Cell Mol Biol; 2018 Jul; 59(1):36-44. PubMed ID: 29337590
[TBL] [Abstract][Full Text] [Related]
20. Pre-emptive Short-term Nicotinamide Mononucleotide Treatment in a Mouse Model of Diabetic Nephropathy.
Yasuda I; Hasegawa K; Sakamaki Y; Muraoka H; Kawaguchi T; Kusahana E; Ono T; Kanda T; Tokuyama H; Wakino S; Itoh H
J Am Soc Nephrol; 2021 Jun; 32(6):1355-1370. PubMed ID: 33795425
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
